Cancer clinical trials in the region Bourgogne-Franche-Comté
161 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3
Rectal cancer
#NCT06402864
#2023-506885-30-00
Adenocarcinoma
Localized
Locally Advanced
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Radiologie (Mâcon)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Breast cancer
#NCT06966700
HER2 Negative
HR Negative
HR Positive
Localized
Locally Advanced
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Radiotherapy
Hormone therapy
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Radiotherapy
Hormone therapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT06908993
#2024-519971-25-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MET
1
2
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
HER2
KRAS non G12C
RET
ROS-1
Systemic Treatment-Naive
Targeted therapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier de Sens (Sens)
Intergroupe Francophone de Cancérologie Thoracique
Phase 3
Stomach and esophageal cancer
#NCT06901531
#2024-519773-19-00
Stomach
Oesogastric junction
Adenocarcinoma
Locally Advanced
Metastatic
Claudin 18.2
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
HER2
Immunotherapy
Chemotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Astellas Pharma Développement mondial, Inc.
Phase 3
Breast cancer
#NCT05514054
#2022-501007-28-00
HER2 Negative
HR Positive
Localized
None
Hormone therapy
Centre Hospitalier Universitaire de Besançon (Besançon)
Eli Lilly et compagnie